Diagnostic and Differential Criteria of Essential Thrombocythemia and Reactive Thrombocytosis

References

• Weinfeld A., Branehög I., Kutti J. Platelets in the myeloproliferative syndrome. Clin. Haematol. 1975; 4: 373–392
   PubMedGoogle Scholar
• Murphy S. Thrombocytosis and thrombocythaemia. Clin. Haematol. 1983; 12: 89–106
   PubMedGoogle Scholar
• Schafer A. I. Bleeding and thrombosis in the myeloproliferative disorders. Blood 1984; 64: 1
   PubMed Web of Science ®Google Scholar
• Kutti J. The management of thrombocytosis. Eur. J. Haematol. 1990; 44: 81–88
   PubMed Web of Science ®Google Scholar
• Fialkow P. J., Fauget G. B., Jacobson R. J., Vaidya K., Murphy S. Evidence that essential thombocythemia is a clonal disorder with origin in a multipotent stem. cell. Blood 1981; 58: 916–919
   PubMed Web of Science ®Google Scholar
• van Genderen P. J. J., Michiels J. J. Primary thrombocythemia: diagnosis, clinical manifestations and management. Ann. Hematol. 1993; 67: 57–62
   PubMed Web of Science ®Google Scholar
• Tobelem G. Essential thrombocythaemia. Bailliere's Clin. Haematol. 1989; 2: 719–778
   PubMedGoogle Scholar
• Buss D. H., Cashell A. W., O'Connor M. L., Richards F., Case L. D. Occurence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases. Am. J. Med. 1994; 96: 247–253
   PubMed Web of Science ®Google Scholar
• Vora A. J., Lilleyman J. S. Secondary thrombocytosis. Arch. Dis. Child. 1993; 68: 88–90
   PubMed Web of Science ®Google Scholar
• Murphy S., Iland H., Rosenthal D., Laszlo J. Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin. Hematol. 1986; 23: 177–182
   PubMed Web of Science ®Google Scholar
• Pearson T. C. Primary thrombocythaemia: diagnosis and management. Br. J. Haematol. 1991; 78: 145–148
   PubMed Web of Science ®Google Scholar
• Wright J. H. The origin and nature of the blood plates. Boston Med. Surg. J. 1906; 154: 643–645
   Google Scholar
• Branehög I., Ridell B., Swolin B., Weinfeld A. Megakaryocyte quantifications in relation to thrombokinetics in primary thrombocythaemia and allied diseases. Scand. J. Haematol. 1975; 15: 321–332
   PubMedGoogle Scholar
• Thiele J., Schneider G., Hoeppner B., Wienhold ST, Zankovich R., Fischer R. Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis—features of significance for the diagnosis of primary (essential) thrombocythaemia. Virchows. Arch. 1988; 413: 407–417
   Web of Science ®Google Scholar
• Ridell B., Kutti J., Revesz P., Bergström S., Enerbäck L. DNA content and nuclear size of megakaryocytes in thrombocythaemia. APMIS 1990; 98: 845–850
   PubMed Web of Science ®Google Scholar
• Nafe R., Georgii A., Kaloutsi V., Fritsch R. S., Choritz H. Planimetric analysis of megakaryocytes in four main groups of chronic myeloproliferative disorders. Virchows. Arch. 1991; 61: 111–116
   Web of Science ®Google Scholar
• Wadenvik H., Kutti J., Ridell B., Revesz P., Jacobsson S., Magnusson B., Westin J., Vilén L. The effect of alpha-interferon on bone marrow megakaryocytes and platelet production rate in essential thrombocythemia. Blood 1991; 77: 2103–2108
   PubMed Web of Science ®Google Scholar
• Jacobsson S., Carneskog J., Ridell B., Wadenvik H., Swolin B., Kutti J. Megakaryocyte DNA content in states of thrombocytosis. A flow cytometric study. Br. J. Haematol. 1994; 87((Suppl 1))247
   Google Scholar
• Michiels J. J., Koudstaal P. J., Mulder A. H., van Vliet H. H. D.M. Transient neurologic and ocular manifestations in primary thrombocythemia. Neurology 1993; 43: 1107–1110
   PubMed Web of Science ®Google Scholar
• Michiels J. J. Criteria for the clinicopathological diagnosis of primary thrombocythaemia. First Meeting of the European Haematology Association. European Working Group on the Myeloproliferative Syndromes. 1994
   Google Scholar
• Dudley J. M., Messinezy M., Eridani S., Holland L. J., Lawrie A., Nunan T. O., Sawer B., Savidge G. F., Pearson T. Primary thrombocythaemia: diagnostic criteria and a simple scoring system for positive diagnosis. Br. J. Haematol. 1989; 71: 331–335
   PubMed Web of Science ®Google Scholar
• Michiels J. J., ten Kate F. J. W. Erythromelalgia in thrombocythemia of various myeloproliferative disorders. Am. J. Hematol. 1992; 39: 131–136
   PubMed Web of Science ®Google Scholar
• Michiels J. J., Abels J., Steketee J., van Vliet H. H. D.M., Vuzevski V. D. Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia. Ann. Intern. Med. 1985; 102: 466–471
   PubMed Web of Science ®Google Scholar
• Drenth J. P. H., Michiels J. J. Erythromelalgia and erythermalgia: diagnostic differentiation. Int. J. Dermatol. 1994; 33: 393–397
   PubMed Web of Science ®Google Scholar
• Komatsu N., Suda T., Sakata Y., Eguchi M., Kaji K., Saito M., Miura Y. Megakaryocytopoiesis in vitro of patients with essential thrombocythaemia: effect of plasma and serum on megakaryocytic colony formation. Br. J. Haematol. 1986; 64: 241–252
   PubMed Web of Science ®Google Scholar
• Juvonen E., Partanen S., Ruutu T. Colony formation by megakaryocytic progenitors in essential thrombocythaemia. Br. J. Haematol. 1987; 66: 161–164
   PubMed Web of Science ®Google Scholar
• Kimura H., Ishibashi T., Sato T., Matsuda S., Uchida T., Kariyone S. Megakaryocytic colony formation (CFU-Meg) in essential thrombocythemia: quantitative and qualitative abnormalities of bone marrow CFU-Meg. Am. J. Hematol. 1987; 24: 23–30
   PubMed Web of Science ®Google Scholar
• Juvonen E., Ikkala E., Oksanen K., Ruutu T. Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications. Br. J. Haematol. 1993; 83: 192–197
   PubMed Web of Science ®Google Scholar
• Rolovic Z., Basara N., Gotic M., Sefer D., Bogdanovic A. The determination of spontaneous colony formation is an unequivocal test for discrimination between essential thrombocythaemia and reactive thrombocytosis. Br. J. Haematol. 1995; 90: 326–331
   PubMed Web of Science ®Google Scholar
• Sawyer B. M., Westwood N. B., Pearson T. C. Circulating megakaryocytic progenitor cells in patients with primary thrombocythaemia and reactive thrombocytosis: results using a serum-deprived culture assay and positive detection technique. Eur. J. Haematol. 1994; 53: 108–113
   PubMed Web of Science ®Google Scholar
• Bellucci S., Janvier M., Tobelem G., Flandrin G., Charpak Y., Berger R., Boiron M. Essential thrombocythemias: clinical evolutionary and biological data. Cancer 1986; 58: 2440–2447
   PubMed Web of Science ®Google Scholar
• Van de Pette J. E. W., Prochazka A. V., Pearson T. C., Singh A. K., Dickson E. R., Wetherley-Mein G. Primary thrombocythaemia treated with busulphan. Br. J. Haematol. 1986; 62: 229–237
   PubMed Web of Science ®Google Scholar
• Hehlmann R., Jahn M., Baumann B., Köpcke W. Essential thrombocythemia. Clinical characteristics and course of 61 cases. Cancer 1988; 61: 2487–2496
   PubMed Web of Science ®Google Scholar
• Tefferi A., Hoagland H. C. Issues in the diagnosis and management of essential thrombocythemia. Mayo. Clin. Proc. 1994; 69: 651–655
   PubMed Web of Science ®Google Scholar
• Messinezy M., Chapman R., Dudley J. M., Nunan T. O., Pearson T. C. Use of splenic volume estimation to distinguish primary thrombocythaemia from reactive thrombocytosis. Eur. J. Haematol. 1988; 40: 339–342
   PubMed Web of Science ®Google Scholar
• Revesz P., Carneskog J., Wadenvik H., Jarneborn L., Kutti J. Measurement of spleen size using gamma camera scintigraphy in essential thrombocythaemia. Eur. J. Haematol. 1993; 51: 141–143
   PubMed Web of Science ®Google Scholar
• Hollen C. W., Henthorn J., Koziol J. A., Burstein S. A. Elevated serum interleukin-6 levels in patients with reactive thrombocytosis. Br. J. Haematol. 1991; 79: 286–290
   PubMed Web of Science ®Google Scholar
• Hollen C. W., Henthorn J., Koziol J. A., Burstein S. A. Serum interleukin-6 levels in patients with thrombocytosis. Leuk. Lymphoma 1992; 8: 235–241
   PubMed Web of Science ®Google Scholar
• Tefferi A., Ho T. C., Ahmann G. J., Katzmann J. A., Greipp P. R. Plasma interleukin-6 and C-reactive protein levels in reactive versus clonal thrombocytosis. Am. J. Med. 1994; 97: 374–378
   PubMed Web of Science ®Google Scholar
• Zahavi J., Zahavi M., Firsteter E., Frish B., Turleanu R., Rachmani R. An abnormal pattern of multiple platelet function abnormalities and increased thromboxane generation in patients with primary thrombocytosis and thrombotic complications. Eur. J. Haematol. 1991; 47: 326–332
   PubMed Web of Science ®Google Scholar
• Majer R. V., Dawe A., Weir P., Jones-Lecointe A., Green P. J. Which tests are most useful in distinguishing between reactive thrombocytosis and the thrombocytosis of myeloproliferative disease?. Clin. Lab. Haematol. 1991; 13: 9–15
   PubMedGoogle Scholar
• Berk P. D., Goldberg J. D., Donovan P. B., Fruchtman S. M., Berlin N. I., Wasserman L. R. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin. Hematol. 1986; 23: 132–143
   PubMed Web of Science ®Google Scholar